Two for One: Targeting BCMA and CD19 in B-cell Malignancies with Off-the-Shelf Dual-CAR NK-92 Cells

By
Justin.choi
-
0
15
Researchers evaluated the functionality of mRNA-engineered dual-CAR NK-92 against tumor B cell lines and primary patient samples.
[Journal of Translational Medicine]

Sorry, but the selected Zotpress account can't be found.

Full Article